Skip to content

Pharma.Tips

Unlocking Pharma's Secrets: Your Ultimate Guide to Pharmaceutical Success!

Tag: Pharmaceutical Insights]

Resolving Layer Delamination in Multi-Layer Tablets Under Stress Testing

Posted on May 19, 2025 By Admin

Resolving Layer Delamination in Multi-Layer Tablets Under Stress Testing Resolving Layer Delamination in Multi-Layer Tablets Under Stress Testing Introduction: In the pharmaceutical industry, multi-layer tablets have become a sophisticated option for delivering multiple active pharmaceutical ingredients (APIs) with distinct release profiles. These tablets offer numerous advantages, including improved patient compliance and efficient dosing schedules. However,…

Read More “Resolving Layer Delamination in Multi-Layer Tablets Under Stress Testing” »

Solid Dosage form, Tablets

Addressing Non-Compliance in QA Tests for Multi-Layer Tablets

Posted on May 16, 2025 By Admin

Addressing Non-Compliance in QA Tests for Multi-Layer Tablets Addressing Non-Compliance in QA Tests for Multi-Layer Tablets Introduction: In the pharmaceutical industry, multi-layer tablets have emerged as a preferred solid dosage form due to their ability to deliver multiple active pharmaceutical ingredients (APIs) in a single dose and to provide controlled release of medications. However, ensuring…

Read More “Addressing Non-Compliance in QA Tests for Multi-Layer Tablets” »

Solid Dosage form, Tablets

Poor reproducibility in API stability data for high-dose capsules.

Posted on April 15, 2025 By Admin

Poor reproducibility in API stability data for high-dose capsules. Poor reproducibility in API stability data for high-dose capsules Introduction: In the pharmaceutical industry, the stability of active pharmaceutical ingredients (APIs) is crucial for ensuring drug safety and efficacy. For high-dose capsules, achieving consistent and reproducible stability data is particularly challenging. Variability in stability data can…

Read More “Poor reproducibility in API stability data for high-dose capsules.” »

Capsules (Hard & Soft Gelatin), Solid Oral Dosage Forms

Poor reproducibility in API release profiles over the product’s shelf life.

Posted on April 4, 2025 By Admin

Poor reproducibility in API release profiles over the product’s shelf life. Poor reproducibility in API release profiles over the product’s shelf life. Introduction: The reproducibility of Active Pharmaceutical Ingredient (API) release profiles is a critical component in the pharmaceutical industry, particularly for solid oral dosage forms such as capsules. Ensuring consistent drug release over a…

Read More “Poor reproducibility in API release profiles over the product’s shelf life.” »

Capsules (Hard & Soft Gelatin), Solid Oral Dosage Forms

Managing Failures in Content Uniformity Tests for Immediate Release Tablets

Posted on March 13, 2025 By Admin

Managing Failures in Content Uniformity Tests for Immediate Release Tablets Managing Failures in Content Uniformity Tests for Immediate Release Tablets Introduction: In the world of pharmaceutical manufacturing, ensuring that each tablet contains the precise amount of active ingredient is crucial for both efficacy and safety. This is particularly true for immediate-release tablets, where rapid onset…

Read More “Managing Failures in Content Uniformity Tests for Immediate Release Tablets” »

Solid Dosage form, Tablets
  • Aerosol Formulations
  • Capsules (Hard & Soft Gelatin)
  • Drug Discovery
  • External Preparations
  • GLP Guidelines
  • GMP Guidelines
  • Medical Devices
  • Parenteral Drug Manufacturing
  • Pharma Quality Control
  • Pharma Research
  • Schedule M
  • Solid Dosage form
  • Solid Oral Dosage Forms
  • Tablets
  • Tablets

Copyright © 2025 Pharma.Tips.

Powered by PressBook WordPress theme